Regulation - Biosimilars, Immunologicals

Filter

Current filters:

BiosimilarsImmunologicals

Popular Filters

FDA staffers back approval of Novartis' biosimilar of Amgen's Neupogen

FDA staffers back approval of Novartis' biosimilar of Amgen's Neupogen

06-01-2015

In briefing papers ahead of an advisory committee meeting, agency staff at the US Food and Drug Administration…

AmgenBiosimilarsBiotechnologyImmunologicalsNeupogenNovartisRegulationUSA

COMPANY SPOTLIGHT

Menarini

Back to top